JP2024540163A5 - - Google Patents

Info

Publication number
JP2024540163A5
JP2024540163A5 JP2024525593A JP2024525593A JP2024540163A5 JP 2024540163 A5 JP2024540163 A5 JP 2024540163A5 JP 2024525593 A JP2024525593 A JP 2024525593A JP 2024525593 A JP2024525593 A JP 2024525593A JP 2024540163 A5 JP2024540163 A5 JP 2024540163A5
Authority
JP
Japan
Application number
JP2024525593A
Other languages
Japanese (ja)
Other versions
JP2024540163A (ja
JPWO2023077070A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/078879 external-priority patent/WO2023077070A1/en
Publication of JP2024540163A publication Critical patent/JP2024540163A/ja
Publication of JP2024540163A5 publication Critical patent/JP2024540163A5/ja
Publication of JPWO2023077070A5 publication Critical patent/JPWO2023077070A5/ja
Pending legal-status Critical Current

Links

JP2024525593A 2021-10-29 2022-10-28 Rxfp1アゴニスト Pending JP2024540163A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163273242P 2021-10-29 2021-10-29
US63/273,242 2021-10-29
PCT/US2022/078879 WO2023077070A1 (en) 2021-10-29 2022-10-28 Rxfp1 agonists

Publications (3)

Publication Number Publication Date
JP2024540163A JP2024540163A (ja) 2024-10-31
JP2024540163A5 true JP2024540163A5 (https=) 2025-10-30
JPWO2023077070A5 JPWO2023077070A5 (https=) 2025-10-30

Family

ID=84363771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525593A Pending JP2024540163A (ja) 2021-10-29 2022-10-28 Rxfp1アゴニスト

Country Status (7)

Country Link
US (1) US20250011288A1 (https=)
EP (1) EP4423068B1 (https=)
JP (1) JP2024540163A (https=)
KR (1) KR20240091018A (https=)
CN (1) CN118510758A (https=)
ES (1) ES3062200T3 (https=)
WO (1) WO2023077070A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121605099A (zh) * 2023-08-10 2026-03-03 深圳信立泰药业股份有限公司 一种rxfp1受体调节剂及其制备方法和医药用途
TW202530177A (zh) * 2023-10-13 2025-08-01 大陸商江蘇恆瑞醫藥股份有限公司 醯胺取代的環烷基類化合物、其製備方法及其在醫藥上的應用
JP7788532B2 (ja) * 2023-12-15 2025-12-18 イーライ リリー アンド カンパニー Rxfp1受容体アゴニスト
WO2026041118A1 (zh) * 2024-08-22 2026-02-26 江苏恒瑞医药股份有限公司 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用
WO2026064271A1 (en) * 2024-09-23 2026-03-26 Fmc Corporation Substituted bicyclic amide derivatives as herbicides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2803920A1 (en) 2010-06-24 2011-12-29 Richard Beard Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
WO2013165606A1 (en) * 2012-05-04 2013-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of the relaxin receptor 1
AR124193A1 (es) * 2020-12-08 2023-02-22 Astrazeneca Ab Compuestos moduladores de rxfp1

Similar Documents

Publication Publication Date Title
JP2024540163A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13164U (https=)
BY13159U (https=)
CN307044974S (https=)
CN307044693S (https=)
CN306958477S8 (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
CN307047630S (https=)